micro dose glp-1 EllieMD Microdosing GLP-1 for Weight Loss

iFIT Trainer John Peel is back with a powerful, 6-part strength series designed to be a part of holistic weight loss journeys, including those using weight l...

Find out if Aetna covers Mounjaro or other GLP-1 weight loss injections

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Backed by strong clinical evidence, GLP-1s are winning over doctors and patients alike and are reshaping treatment paradigms across comorbid conditions

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the therapeutic landscape of type 2 diabetes (T2D) and obesity by offering substantial weight loss and cardiometabolic protection

prices closer to global standards.